Biodegradation kinetic constants and sorption coefficients of micropollutants in membrane bioreactors

Biodegradation

Volumn 24, Issue 2, 2013, Pages 165-177

  Fernandez Fontaina, Eduardo ^a   Pinho, Ines ^a   Carballa, Marta ^a   Omil, Francisco ^a   Lema, Juan M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Activated sludge; Biodegradation; Micropollutants; Musk fragrances; Pharmaceuticals; Sorption

Indexed keywords

ACTIVATED SLUDGE; BIODEGRADATION KINETIC CONSTANTS; BIOLOGICAL DEGRADATION; BIOMASS CONCENTRATIONS; CONVENTIONAL ACTIVATED SLUDGES; HETEROTROPHIC BIOMASS; KINETIC CONSTANT; LITERATURE DATA; MEMBRANE BIO REACTOR (MBR); MEMBRANE BIOREACTOR; MICROPOLLUTANTS; MUSK FRAGRANCES; PARTITION COEFFICIENT; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; REMOVAL EFFICIENCIES; SLUDGE RETENTION; SOLID-LIQUID; SOLID-PHASE CONCENTRATION; SORPTION COEFFICIENTS;

ACTIVATED SLUDGE PROCESS; BATCH REACTORS; BIOMASS; BIOREACTORS; DRUG PRODUCTS; MICROBIOLOGY; SORPTION;

BIODEGRADATION;

CHARCOAL;

ACTIVATED SLUDGE; BIODEGRADATION; BIOREACTOR; CONCENTRATION (COMPOSITION); DRUG; MEMBRANE; POLLUTANT; REACTION KINETICS; SORPTION;

ARTICLE; ARTIFICIAL MEMBRANE; BIOREACTOR; BIOREMEDIATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; SEWAGE; WATER MANAGEMENT; WATER POLLUTANT;

BIODEGRADATION, ENVIRONMENTAL; BIOREACTORS; CHARCOAL; MEMBRANES, ARTIFICIAL; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84874577781     PISSN: 09239820     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10532-012-9568-3     Document Type: Article

References (42)

1. Abegglen C et al (2009) The fate of selected micropollutants in a single-house MBR. Water Res 43(7): 2036-2046.
2. APHA (1998) Standard methods for the examination of water and wastewater, 20th edn. American Public Health Association/American Water Works Association/Water Environment Federation, Washington DC.
3. Bernhard M, Müller J, Knepper TP (2006) Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res 40(18): 3419-3428.
4. 14C-radiolabelled diclofenac and 4′-hydroxydiclofenac in membrane bioreactor treatment of wastewater. Water Sci Technol 63(12): 2878-2885.
5. Carballa M et al (2004) Behaviour of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12): 2918-2926.
6. Clara M, Strenn B, Kreuzinger N (2004) Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 38(4): 947-954.
7. Clara M et al (2005a) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39(19): 4797-4807.
8. Clara M et al (2005b) The solids retention time--a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39(1): 97-106.
9. Delgadillo-Mirquez L et al (2011) A new dynamic model for bioavailability and cometabolism of micropollutants during anaerobic digestion. Water Res 45(15): 4511-4521.
10. Dietrich S et al (2010) Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia Magna--a multigenerational study. Chemosphere 79(1): 60-66.
11. Durante F et al (2006) Particle size distribution and biomass growth in a submerged membrane bioreactor. Desalination 199(1-3): 493-495.
12. Göbel A et al (2005) Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 39(11): 3981-3989.
13. Göbel A et al (2007) Fate of sulfonamides, macrolides and trimethoprim in different wastewater treatment technologies. Sci Total Environ 372(2-3): 361-371.
14. Heberer T, Reddersen K, Mechlinski A (2002) From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol 46(3): 81-88.
15. Horii Y et al (2007) Occurrence and fate of polycyclic musks in wastewater treatment plants in Kentucky and Georgia, USA. Chemosphere 68(11): 2011-2020.
16. Joss A et al (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40(8): 1686-1696.
17. Kannan K et al (2005) Polycyclic musk compounds in higher trophic level aquatic organisms and humans from the United States. Chemosphere 61(5): 693-700.
18. Kimura K, Hara H, Watanabe Y (2005) Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 178(1-3): 135-140.
19. Kimura K, Hara H, Watanabe Y (2007) Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 41(10): 3708-3714.
20. Lindblom E et al (2006) Integrated modelling of two xenobiotic organic compounds. Water Sci Technol 54(6-7): 213-221.
21. Martins da Costa P, Vaz-Pires P, Bernardo F (2006) Antimicrobial resistance in enterococcus spp. isolated in inflow, effluent and sludge from municipal sewage water treatment plant. Water Res 40(8): 1735-1740.
22. Masse A, Sperandio M, Cabassud C (2006) Comparison of sludge characteristic and performance of a submerged membrane bioreactor and an activated sludge process at high solids retention time. Water Res 40(12): 2405-2415.
23. McArdell C et al (2005) Sorption of pharmaceuticals and personal care products to activated sludge. SETAC Europe Meeting, Lille.
24. Miege C et al (2009) Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results. Environ Pollut 157(5): 1721-1726.
25. Onesios KM, Yu JT, Bouwer EJ (2009) Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 20(4): 441-466.
26. Peng X et al (2006) A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewaters of two sewage treatment plants in Guangzhou, China. Sci Total Environ 371(1-3): 314-322.
27. Radjenovic J, Petrovic M, Barceló D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387(4): 1365-1377.
28. Radjenovic J, Petrovic M, Barcelo D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43(3): 831-841.
29. Reif R (2011) Feasibility of membrane bioreactors for the removal of pharmaceutical and personal care products present in sewage. PhD Dissertation, University of Santiago de Compostela.
30. Reif R et al (2008) Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 221(1-3): 511-517.
31. Reif R et al (2011) Comparison of PPCPs removal on a parallel-operated MBR and AS system and evaluation of effluent post-treatment on vertical flow reed beds. Water Sci Technol 63(10): 2411-2417.
32. Roig B (2010) Pharmaceuticals in the environment. Current knowledge and need assessment to reduce presence and impact. IWA Publishing, London.
33. Rojas MEH et al (2005) Role and variations of supernatant compounds in submerged membrane bioreactor fouling. Desalination 179(1-3): 95-107.
34. Sipma J et al (2010) Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 250(2): 653-659.
35. Suarez S, Omil F, Lema JM (2010) Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res 44(10): 3214-3224.
36. Schwarzenbach RP, Gschwend PM, Imboden DM (2003) Environmental organic chemistry. Wiley, Hoboken.
37. Suarez S et al. (2012) Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system. Influence of T, SRT and recirculation ratio. Chemosphere. http://dx. doi. org/10. 1016/j. chemosphere. 2012. 05. 094.
38. Tambosi JL et al (2010) Removal of pharmaceutical compound in membrane bioreactors (MBR) applying submerged membranes. Desalination 261(1-2): 148-156.
39. d) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38(19): 4075-4084.
40. Ternes TA et al (2005) Determination of pharmaceuticals, iodinated contrast media and musk fragrances in sludge by LC/tandem MS and GC/MS. J Chromatogr A 1067(1-2): 213-223.
41. Urase T, Kikuta T (2005) Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res 39(7): 1289-1300.
42. Vasskog T et al (2006) Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J Chromatogr A 1115(1-2): 187-195.